Horizon Therapeutics Public Ltd Co Debt Conversion, Converted Instrument, Amount
Horizon Therapeutics Public Ltd Co reported Debt Conversion, Converted Instrument, Amount of $398.26 million for the 12-month period ending 2020-12-31, per its 10-K filed 2023-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2023-03-01
- Horizon Therapeutics Public Ltd Co debt conversion, converted instrument, amount for the quarter ending 2020-12-31 was $0.00.
- Horizon Therapeutics Public Ltd Co debt conversion, converted instrument, amount for the quarter ending 2020-09-30 was $191.22M.
- Horizon Therapeutics Public Ltd Co debt conversion, converted instrument, amount for the quarter ending 2014-12-31 was $89.00M.
- Horizon Therapeutics Public Ltd Co debt conversion, converted instrument, amount for fiscal 2020 was $398.26M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $191.22M derived: sum of 2 quarters · filed 2023-03-01 | $398.26M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $191.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $398.26M 10-Q · filed 2021-11-03 | ||
| 2020-06-30 | $207.04M 10-Q · filed 2021-08-04 | |||
| 2014-12-31 | $89.00M 10-K · filed 2016-02-29 |